Ovid Therapeutics Statistics

Total Valuation

OVID has a market cap or net worth of $84.46 million. The enterprise value is $22.87 million.

Market Cap	84.46M
Enterprise Value	22.87M

Important Dates

The next estimated earnings date is Friday, November 1, 2024, before market open.

Earnings Date	Nov 1, 2024
Ex-Dividend Date	n/a

Share Statistics

OVID has 70.97 million shares outstanding. The number of shares has increased by 0.35% in one year.

Shares Outstanding	70.97M
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.68%
Owned by Insiders (%)	5.22%
Owned by Institutions (%)	36.10%
Float	46.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	148.29
Forward PS	219.55
PB Ratio	0.95
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	40.29
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.73, with a Debt / Equity ratio of 0.17.

Current Ratio	5.73
Quick Ratio	5.45
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -29.81% and return on invested capital (ROIC) is -35.85%.

Return on Equity (ROE)	-29.81%
Return on Assets (ROA)	-32.61%
Return on Capital (ROIC)	-35.85%
Revenue Per Employee	$14,192
Profits Per Employee	-$743,699
Employee Count	40
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.71% in the last 52 weeks. The beta is 0.39, so OVID's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	-65.71%
50-Day Moving Average	1.14
200-Day Moving Average	2.26
Relative Strength Index (RSI)	55.91
Average Volume (20 Days)	105,023

Short Selling Information

The latest short interest is 633,880, so 0.89% of the outstanding shares have been sold short.

Short Interest	633,880
Short Previous Month	653,891
Short % of Shares Out	0.89%
Short % of Float	1.36%
Short Ratio (days to cover)	4.10

Income Statement

In the last 12 months, OVID had revenue of $567,695 and -$29.75 million in losses. Loss per share was -$0.42.

Revenue	567,695
Gross Profit	567,695
Operating Income	-66.35M
Pretax Income	-50.68M
Net Income	-29.75M
EBITDA	-65.78M
EBIT	-66.35M
Loss Per Share	-$0.42

Full Income Statement

Balance Sheet

The company has $76.97 million in cash and $15.39 million in debt, giving a net cash position of $61.58 million or $0.87 per share.

Cash & Cash Equivalents	76.97M
Total Debt	15.39M
Net Cash	61.58M
Net Cash Per Share	$0.87
Equity (Book Value)	88.90M
Book Value Per Share	1.25
Working Capital	66.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$52.90 million and capital expenditures -$72,308, giving a free cash flow of -$52.98 million.

Operating Cash Flow	-52.90M
Capital Expenditures	-72,308
Free Cash Flow	-52.98M
FCF Per Share	-$0.75

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-11,687.87%
Pretax Margin	-5,240.13%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-10,643.44%

Dividends & Yields

OVID does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.35%
Shareholder Yield	-0.35%
Earnings Yield	-35.22%
FCF Yield	-62.73%

Analyst Forecast

The average price target for OVID is $4.04, which is 239.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.04
Price Target Difference	239.50%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	183.67%
EPS Growth Forecast (5Y)	-10.82%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OVID has an Altman Z-Score of 0.27 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.27
Piotroski F-Score	1